Article Text

Download PDFPDF
Vessel restenosis versus “streamlining”
  1. C E Mullins
  1. Correspondence to:
    Charles E Mullins, MD, Baylor College of Medicine, Cardiac Catheterization Laboratories, Texas Children’s Hospital, 6621 Fannin Street, Houston, Texas 77030, USA;

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Paediatric patients grow, therefore implanted stents must be capable of being redilated in order to accommodate this growth

Restenosis secondary to intimal hyperplasia within small diameter intravascular stents is a major problem in the adult population with atherosclerotic vascular disease. In contrast, most large series of stent implants in congenital lesions suggest that restenosis is rarely a problem. Schneider and colleagues, in this issue of Heart,1 point out that paediatric patients grow and that stents implanted in the paediatric population must be capable of being redilated to accommodate for the growth of the patient. Vessel growth occurs in proportion to the patient’s relative somatic growth rather than simply in relation to weight gain, and growth related relative stenosis of the appropriately stented vessel is unlikely until the patient’s body (and his vessels) have grown 30–50%.2

In a large series with medium to long term follow up at the Texas Children’s Hospital, excessive intimal hyperplasia within stents occurred only rarely.3–5 When it does occur, there is usually some abnormality of the tissues and/or the stent implant, and the intimal hyperplasia usually does not result in a stenosis or restenosis of the vessels. Intimal hyperplasia most frequently …

View Full Text